In what’s expected to be one of AbbVie’s “biggest new product launches” in the coming years, the company has hit a snag with its regulatory efforts.
AbbVie's blockbuster-to-be Parkinson's co... - Cure Parkinson's
AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump
Written by
Farooqji
To view profiles and participate in discussions please or .
4 Replies
•
US FDA declines to approve AbbVie's Parkinson's diseasetherapy
m.investing.com/news/stock-...
The FDA has issued a complete response letter for Abbvie's infusion therapy for Parkinsons, citing a need for more information on the device used to administer the treatment
Hopefully Abbvie’s resubmission will satisfy the FDA.
It appears that there is a big pharma company paying someone (or more than one) in the FDA to postpone approval until their product is marketable. Manipulation for market share is rampant. This is my humble opinion.
Not what you're looking for?
You may also like...
Research finds Taurine to be neuroprotective in a Parkinson's disease mouse model
Prof. Frank Church has done a blog post on some recent Chinese research into the neuroprotective...
Do you have a theory as to what caused you, personally, to develop 'Parkinson's'?
Now that you have developed'Parkinson's' and have probably done some reading, discussed or carried...
Will Tasigna, an FDA-approved cancer drug, be the first drug to revere symptoms of Parkinson's and dementia?
At their best, drugs for Parkinson's disease (PD) only slow the progression of the disease. But...
Based On Newer Studies, It May Be Time To Rethink The Importance Of Vitamin D in Parkinson's Disease Progression As Well As Other Diseases
I previously wrote extensively about the value of vitamin D in PD here:...
As a caregiver, can anyone help me with suggestions on how to handle the dementia aspect of Parkinson's?
Okay, I know I just threw an arrow into a very dense forest without aiming on that question-but...